Remixing reproduction and genetics
The European Society of Human Reproduction and Embryology (ESHRE) held their annual meeting in Tours last week. The European Society of Human Genetics (ESHG) held theirs in Geneva at the end of May...
Patron of PET
Professor Marcus Pembrey is a Patron of the Progress Educational Trust (PET), where he previously served as Chair of Trustees for more than 20 years. He was also a member of PET's precursor organisation, the Progress Campaign for Research into Human Reproduction. He is Emeritus Professor of Paediatric Genetics at University College London's Institute of Child Health, Visiting Professor of Paediatric Genetics at the University of Bristol, and a Fellow of the Academy of Medical Sciences. He was previously Consultant Adviser in Genetics to the Chief Medical Officer at the UK Government's Department of Health, Consultant Clinical Geneticist at Great Ormond Street Hospital for Children, Vice Dean of the Institute of Child Health, President of the European Society of Human Genetics, and co-founder of the International Federation of Human Genetic Societies.
Marcus and his colleagues helped to pioneer the use of DNA testing in genetic counselling and prenatal diagnosis, within the services provided to families affected by genetic disease. Alongside his research into rare genetic syndromes showing unusual patterns of inheritance, he helped Professor Jean Golding establish the Avon Longitudinal Study of Parents and Children, also known as 'Children of the 90s', and subsequently worked as that project's Director of Genetics. He has written more than 150 peer-reviewed papers in journals including Cell, the Lancet, Nature and Science, as well as writing textbooks and guides for the general public. More recently, his research has focused on environmental epigenomics and transgenerational responses.
The European Society of Human Reproduction and Embryology (ESHRE) held their annual meeting in Tours last week. The European Society of Human Genetics (ESHG) held theirs in Geneva at the end of May...
The Wellcome Trust is to fund 67% of a two year, $45m (£30m), international project to define some 300,000 DNA sequence variations in the human genome. The remaining funds come from a consortium of ten of the world's leading pharmaceutical companies, who have also agreed to put the newly discovered...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.